Assessing the Antifungal Activity of a New Oral Lipid-Based Amphotericin B Formulation Following Administration to Rats Infected with Aspergillus Fumigatus

By Risovic Verica   Rosland Mike   Sivak Olena   Wasan Kishor M.   Bartlett Karen  

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 7, 2007-07 ,pp. : 703-707

Informa Healthcare

Access to resources Recommend Favorite

The Use of Lipid-Based Formulations to Increase the Oral Bioavailability of Panax Notoginseng Saponins Following a Single Oral Gavage to Rats

By Xiong Jing   Guo Jianxin   Huang Luosheng   Meng Boyu   Ping Qineng  

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 1, 2008-01 ,pp. : 65-72

Informa Healthcare

Access to resources Recommend Favorite

Lymphatic transport of puerarin occurs after oral administration of different lipid-based formulations to unconscious lymph duct-cannulated rats

By Zhou An   Lu Tao   Wang Lei   Lu Chuanhua   Wang Lina   Wan Maolin   Wu Hongfei  

Pharmaceutical Development and Technology, Vol. 19, Iss. 6, 2014-09 ,pp. : 743-747

Informa Healthcare

Access to resources Recommend Favorite

Differences in human phospholipid transfer protein activity following incubation of Fungizone® compared to lipid-based Amphotericin-B formulations in normolipidemic and hyperlipidemic plasma

By Henderson Ryan J.   Leon Carlos G.   Wasan Kishor M.  

Drug Development and Industrial Pharmacy, Vol. 35, Iss. 9, 2009-09 ,pp. : 1139-1146

Informa Healthcare

Access to resources Recommend Favorite

The lipid formulations of amphotericin B

By Herbrecht Raoul   Natarajan-Amé Shanti   Nivoix Yasmine   Letscher-Bru Valérie  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 8, 2003-08 ,pp. : 1277-1287

Informa Healthcare

Access to resources Recommend Favorite